WilliamSMakarowskiMD

PubMed

• 11 citations
  The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee
  William Makarowski, Arthur L. Weaver, Bernard R. Rubin, Jacques Caldwell, F. Gilbert McMahon, Robert J. Noveck, David Lee, Howard Offenberg, Marshall Sack, David Sikes...> ;Clinical Therapeutics. 1996 Jan 1
• 22 citations
  Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee
  Arthur L. Weaver, Bernard R. Rubin, Jacques Caldwell, F.Gilbert McMahon, David Lee, William Makarowski, Howard Offenberg, Marshall Sack, David Sikes, Robert Trapp, Sus...> ;Clinical Therapeutics. 1995 Jul 1
• Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled compariso...
  Makarowski, W., Zhao, W. W., Bevirt, T., Recker, D. P.> ;Osteoarthr Cartil. 2002 Apr
• Hypothyroidism with presenting symptoms of fibrositis.
  Wilke, W. S., Sheeler, L. R., Makarowski, W. S.> ;J Rheumatol. 1981 Jul 01
• Join now to see all